SNDK

Sandisk Corporation

79
Fundamentals88/ 100
Valuation50/ 100
Upside potential69/ 100
Risk potential51/ 100

SNDK has the edge over TRT overall, supported by stronger valuation and stronger fundamentals.

TRT

Trio-Tech International

52
Fundamentals70/ 100
Valuation15/ 100
Upside potential63/ 100
Risk potential31/ 100

TRT has lower modeled downside risk, despite its lower overall score.

SNDK Fundamentals

MetricStatus
Strong
Strong
Strong
Strong

SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.

TRT Fundamentals

MetricStatus
Healthy
Healthy
Under pressure
Strong

TRT's revenue, profitability and balance sheet are currently healthy, but its cash flow is under pressure.

SNDK PE Valuation

CHEAPFAIREXPENSIVE20x39x59x79x
CHEAPFAIREXPENSIVE20x39x59x79x
LevelPEPriceVs current
Forward3.8x$937—
Current7.5x$937—
Cheap17x$2,173+132%
Fair24x$3,048+225%
Expensive59x$7,452+695%

Historical ranges are pointers, not guarantees.

SNDK has the edge over TRT in the historical PE scenario, which offers more potential upside but is not a forecast.

TRT PE Valuation

CHEAPFAIREXPENSIVE116x232x348x463x
CHEAPFAIREXPENSIVE116x232x348x463x
LevelPEPriceVs current
Cheap9.4x$0.56-90%
Fair24x$1.46-74%
Expensive47x$2.81-50%
Current93x$5.60—

Historical ranges are pointers, not guarantees.

TRT's PE is in its expensive range at 93x.

SNDK Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Moderate
High

Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.

TRT Forward outlook

There aren't enough analyst estimates for TRT to show an outlook.

SNDK Risk to reward

ScenarioChangePrice
Upside+113%$1,996.75
Downside-51%$461.20

Calculated from the latest close: $937.46 on Nov 12.

SNDK has a better modeled risk to reward balance than TRT, with more potential upside relative to its potential downside.

TRT Risk to reward

ScenarioChangePrice
Upside+53%$8.58
Downside-31%$3.86

Calculated from the latest close: $5.60 on Nov 12.

TRT trails SNDK on modeled risk to reward, with less potential upside relative to its potential downside.

SNDK Earnings Per Share

Q2 2024: $-4.66Q2 2025: $-11.31Q4 2025: $-12.02Q1 2026: $-7.59Q2 2026: $28.77Q3 2026: $73.76Q4 2026: $125.61Forward: $247.30
Q2 2024: $-4.66Q2 2025: $-11.31Q4 2025: $-12.02Q1 2026: $-7.59Q2 2026: $28.77Q3 2026: $73.76Q4 2026: $125.61Forward: $247.30
QuarterTTM EPSYoY
Forward$247.30+97%
Q3 2026$125.61+$137.63
Q2 2026$73.76+$85.07
Q2 2025-$11.31-$6.65

SNDK has the edge over TRT in the latest year-over-year earnings comparison.

TRT Earnings Per Share

Q4 2023: $0.11Q1 2024: $0.12Q2 2024: $0.12Q3 2024: $0.06Q4 2024: $0.06Q1 2025: $-0.01Q2 2025: $-0.01Q3 2025: $0.03Q4 2025: $-0.01Q1 2026: $0.04Q2 2026: $0.00Q3 2026: $0.06
Q4 2023: $0.11Q1 2024: $0.12Q2 2024: $0.12Q3 2024: $0.06Q4 2024: $0.06Q1 2025: $-0.01Q2 2025: $-0.01Q3 2025: $0.03Q4 2025: $-0.01Q1 2026: $0.04Q2 2026: $0.00Q3 2026: $0.06
QuarterTTM EPSYoY
Q3 2026$0.06+100%
Q2 2026$0.00+$0.01
Q1 2026$0.04+$0.05
Q4 2025-$0.01-117%
Q3 2025$0.03-50%
Q2 2025-$0.01-108%
Q1 2025-$0.01-108%
Q4 2024$0.06-45%

TRT's earnings per share have fallen from their peak: $0.06 over the past year, against $0.28 in mid-2022.

SNDK Quarterly Revenue

Q1 2024: $1.7BQ2 2024: $1.8BQ3 2024: --Q3 2024: $1.9BQ4 2024: $1.9BQ1 2025: $1.7BQ2 2025: $1.9BQ4 2025: $2.3BQ1 2026: $3BQ2 2026: $6BQ3 2026: $9BQ4 2026: $11B
Q1 2024: $1.7BQ2 2024: $1.8BQ3 2024: --Q3 2024: $1.9BQ4 2024: $1.9BQ1 2025: $1.7BQ2 2025: $1.9BQ4 2025: $2.3BQ1 2026: $3BQ2 2026: $6BQ3 2026: $9BQ4 2026: $11B
QuarterRevenueYoY
Q3 2026$11B+378%
Q2 2026$9B+372%
Q1 2026$6B+251%
Q4 2025$3B+61%
Q3 2025$2.3B+23%
Q2 2025$1.9B+8%
Q1 2025$1.7B-0.6%
Q4 2024$1.9B+13%

SNDK has the edge over TRT on sales, with more consistent year-over-year improvement.

TRT Quarterly Revenue

Q4 2023: $12MQ1 2024: $10MQ2 2024: $10MQ3 2024: $10MQ4 2024: $9MQ1 2025: $7MQ2 2025: $11MQ3 2025: $16MQ4 2025: $16MQ1 2026: $17MQ2 2026: $15MQ3 2026: $20M
Q4 2023: $12MQ1 2024: $10MQ2 2024: $10MQ3 2024: $10MQ4 2024: $9MQ1 2025: $7MQ2 2025: $11MQ3 2025: $16MQ4 2025: $16MQ1 2026: $17MQ2 2026: $15MQ3 2026: $20M
QuarterRevenueYoY
Q3 2026$19.9M+29%
Q2 2026$14.9M+40%
Q1 2026$16.5M+124%
Q4 2025$15.6M+82%
Q3 2025$15.5M+58%
Q2 2025$10.7M+9.5%
Q1 2025$7.4M-29%
Q4 2024$8.6M-29%

TRT's revenue has grown year over year for six quarters in a row: $20M last quarter, up 29% from the same quarter a year ago.

SNDK Free Cash Flow

Q1 2024: −$41MQ2 2024: −$168MQ3 2024: −$198MQ3 2024: --Q4 2024: --Q1 2025: −$18MQ2 2025: $49MQ4 2025: $438MQ1 2026: $980MQ2 2026: $3BQ3 2026: $7.1BQ4 2026: $6.3B
Q1 2024: −$41MQ2 2024: −$168MQ3 2024: −$198MQ3 2024: --Q4 2024: --Q1 2025: −$18MQ2 2025: $49MQ4 2025: $438MQ1 2026: $980MQ2 2026: $3BQ3 2026: $7.1BQ4 2026: $6.3B
QuarterFree cash flowYoY
Q3 2026$6.3B+1340%
Q2 2026$7.1B+14355%
Q1 2026$3B+$3B
Q3 2025$438M+$636M
Q2 2025$49M+$217M
Q1 2025-$18M+$23M
Q3 2024-$198M-$157M

SNDK has the edge over TRT on cash generation, producing positive trailing cash flow while its opponent burns cash.

TRT Free Cash Flow

Q4 2023: --Q1 2024: $1MQ2 2024: −$289,000Q3 2024: −$2MQ4 2024: $2MQ1 2025: $623,000Q2 2025: −$1MQ3 2025: $887,000Q4 2025: −$152,000Q1 2026: $707,000Q2 2026: $244,000Q3 2026: −$4M
Q4 2023: --Q1 2024: $1MQ2 2024: −$289,000Q3 2024: −$2MQ4 2024: $2MQ1 2025: $623,000Q2 2025: −$1MQ3 2025: $887,000Q4 2025: −$152,000Q1 2026: $707,000Q2 2026: $244,000Q3 2026: −$4M
QuarterFree cash flowYoY
Q3 2026-$4.1M-567%
Q2 2026$244K+$1.5M
Q1 2026$707K+13%
Q4 2025-$152K-108%
Q3 2025$887K+$2.8M
Q2 2025-$1.2M-$932K
Q1 2025$623K-48%
Q2 2024-$289K-123%

TRT's free cash flow was −$3M over the past year, against $2M the year before.

SNDK Total Shares

Q1 2024: 145MQ2 2024: 145MQ3 2024: 145MQ4 2024: 145MQ1 2025: 145MQ2 2025: 145MQ4 2025: 149MQ1 2026: 156MQ2 2026: 157MQ3 2026: 155MQ4 2026: 154M
Q1 2024: 145MQ2 2024: 145MQ3 2024: 145MQ4 2024: 145MQ1 2025: 145MQ2 2025: 145MQ4 2025: 149MQ1 2026: 156MQ2 2026: 157MQ3 2026: 155MQ4 2026: 154M
PeriodChange %Net change
Quarterly-0.6%-1M shares
1 year+3.4%+5M shares
3 years+6.9%+10M shares

SNDK has the edge over TRT on shareholder dilution, with a more favorable share count trend.

TRT Total Shares

Q4 2023: 9MQ1 2024: 9MQ2 2024: 9MQ3 2024: 9MQ4 2024: 9MQ1 2025: 9MQ2 2025: 9MQ3 2025: 9MQ4 2025: 9MQ1 2026: 10MQ2 2026: 9MQ3 2026: 11M
Q4 2023: 9MQ1 2024: 9MQ2 2024: 9MQ3 2024: 9MQ4 2024: 9MQ1 2025: 9MQ2 2025: 9MQ3 2025: 9MQ4 2025: 9MQ1 2026: 10MQ2 2026: 9MQ3 2026: 11M
PeriodChange %Net change
Quarterly+27%+2.4M shares
1 year+31%+2.7M shares
3 years+33%+2.8M shares
5 years+42%+3.4M shares

TRT has 11M diluted shares, up 31% from a year ago.

SNDK Net Leverage

Q2 2026: -0.7xQ3 2026: -0.4xQ4 2026: -0.2x
Q2 2026: -0.7xQ3 2026: -0.4xQ4 2026: -0.2x
QuarterNet LeverageStatus
Q3 2026-0.2xNet Cash
Q2 2026-0.4xNet Cash
Q1 2026-0.7xNet Cash

SNDK has more cash than debt.

TRT Net Leverage

Q4 2023: -1.5xQ1 2024: -1.7xQ2 2024: -1.7xQ3 2024: -1.7xQ4 2024: -2.8xQ1 2025: -3.5xQ2 2025: -3.4xQ3 2025: -4.3xQ4 2025: -4.6xQ1 2026: -4.5xQ2 2026: -10.1xQ3 2026: -4.9x
Q4 2023: -1.5xQ1 2024: -1.7xQ2 2024: -1.7xQ3 2024: -1.7xQ4 2024: -2.8xQ1 2025: -3.5xQ2 2025: -3.4xQ3 2025: -4.3xQ4 2025: -4.6xQ1 2026: -4.5xQ2 2026: -10.1xQ3 2026: -4.9x
QuarterNet LeverageStatus
Q3 2026-4.9xNet Cash
Q2 2026-10.1xNet Cash
Q1 2026-4.5xNet Cash
Q4 2025-4.6xNet Cash
Q3 2025-4.3xNet Cash
Q2 2025-3.4xNet Cash
Q1 2025-3.5xNet Cash
Q4 2024-2.8xNet Cash

TRT has the edge over SNDK on leverage, with a lower net debt burden relative to earnings.

SNDK Weekly Momentum

MetricValueStatus
RSI40.2Neutral
Stochastic10.6Oversold

SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).

TRT Weekly Momentum

MetricValueStatus
RSI41.4Neutral
Stochastic7.5Oversold

TRT's weekly RSI is 41 (neutral) and its Stochastic is 8 (oversold).

SNDK PE vs Technology Sector

MetricSNDKSector medianRelative
PE7.5x28x73% below
PE %42723 pts below

SNDK has the edge over TRT on valuation relative to its sector.

TRT PE vs Technology Sector

MetricTRTSector medianRelative
PE93x28x235% above
PE %883553 pts above

TRT is trading at 93x earnings, a 235% premium to the Technology sector's median of 28x.

SNDK Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$1,317.529% below
20 week MA$1,465.436% below
50 week MA$1,119.616% below

TRT has stronger trend alignment. SNDK is above 0 of 3 weekly averages versus TRT above 2 of 5.

TRT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$5.403.7% above
20 week MA$8.4334% below
50 week MA$8.4734% below
100 week MA$5.722.1% below
200 week MA$4.2931% above

TRT's trend is mixed: it's above two of its five weekly moving averages, and 31% above its 200-week average.

SNDK Yearly ROI

YearStart priceEnd priceROI
2025$50.4$250.1+396%
2026 YTD$250.1$937.5+275%

SNDK has the edge over TRT on returns for 2026, with the stronger performance.

TRT Yearly ROI

YearStart priceEnd priceROI
2020$2.11$1.96-7.1%
2021$1.96$6.27+220%
2022$6.27$2.29-63%
2023$2.29$2.54+11%
2024$2.54$2.96+17%
2025$2.96$7.00+136%
2026 YTD$7.00$5.60-20%

TRT's yearly returns have swung widely, from +220% in 2021 to −63% in 2022. It's down 20% so far in 2026.

Give your agent the market.

Get API key